Saturn Partners

Since 1994, Saturn Partners has taken an active role in the formation and management of seed and early-stage technology companies. Saturn looks for companies with potential for significant growth, primarily in information and financial technology, but also in advanced materials and specialty energy.

We enjoy the challenge of rolling up our sleeves and teaming with creative entrepreneurs to build great companies. We’re not the type of investors to just take part in the board call each quarter. When you need us, we’ll be there with the capital and operational expertise necessary to unleash your company’s potential.

Initial investments typically range from $1 million to $3 million, with reserve amounts varying based on each company’s expected future needs.

Saturn Partners, established in 1994 and headquartered in United States, North America., specializes in Early Stage Venture, Seed, Late Stage Venture investments across Biotechnology, Health Care, Medical, Health Diagnostics, Enterprise Software, Software, Video, Presentations, AgTech, Waste Management. The organization boasts a portfolio of 24 investments, with an average round size of $29.2M and 3 successful exits. Their recent investments include Knopp Biosciences, LaunchCyte, Panopto, BiOWiSH Technologies, Think Through Learning. The highest investment round they participated in was $56.1B. Among their most notable exits are Knopp Biosciences and LaunchCyte. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.